XRP2.F Silence Therapeutics PLC R | US82686Q1013
| Metric | Current | 31.03.2026 | 31.12.2025 | 30.09.2025 |
|---|---|---|---|---|
| Market Cap | 446.367.072 | 654.671.724,58 | 722.679.411,29 | 648.994.453,03 |
| Enterprise Value | 378.780.512 | 649.150.724,58 | 711.562.411,29 | 567.145.453,03 |
| Trailing P/E | - | - | - | - |
| Forward P/E | - | - | - | - |
| Price to Sales | 532,02 | 780,3 | 1.292,81 | 1.236,18 |
| Price to Book | 10,33 | 13,25 | 11,6 | 8,76 |
| EV/Revenue | 451,47 | 773,72 | 1.272,92 | 1.080,28 |
| EV/EBITDA | -5,33 | - | - | - |